Drugs and Therapies - Kinase Inhibitors; Recent Findings from University Hospital of Parma Has Provided New Data on Kinase Inhibitors (Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review)
Drug Week, 2018, p.2564Atlanta: NewsRx
Texto completo disponible